NSC22850 is a specialty chemical reagent primarily utilized in research settings for its potential as an anticancer agent. It is a niche compound investigated in oncology, targeting specific cellular pathways to inhibit tumor growth. Studies employ it in preclinical trials to evaluate efficacy and safety across various cancer models. Additionally, it is explored for synergizing with other chemotherapeutic agents to reduce dosages and side effects. In molecular biology, it aids in elucidating cell cycle regulation and apoptosis mechanisms.